27 May 2023
REAC neurobiological modulation in the treatment of fibromyalgia: new clinical perspectives
A clinical trial evaluates the REAC NPO and NPPO protocols on mobility and quality of life in patients with fibromyalgia syndrome.
News
Published studies, congresses and updates on REAC® Technology and ASMED® devices.
Reserved access
Access to the display of medical devices and information material is reserved for operators in the sector, in compliance with current legislation.
Continuing the navigation I declare to be a professional health worker.
EnterFor information on treatments you can contact the Rinaldi Fontani Institute in Florence.
Go to irf.itLegislative Decree No 46 of 24 February 1997 — Article 21